Latest Breaking News On - Dan eramian - Page 1 : comparemela.com

HighField Biopharmaceuticals HF1K16 Phase 1a Data Suggests the New Immuno-Oncology Drug is Safe, Well-Tolerated and Efficacious in Solid Tumors

HANGZHOU, China (BUSINESS WIRE) Jan 8, 2024

Dan eramianDonald wyattYuhong xuBusiness development contactOpus biotech communicationsField biopharmaceuticalsMedia contactDevelopment contactBusiness wireNation world

HighField Biopharmaceuticals Receives US FDA IND Clearance for Phase 1 Trial of Immunoliposome HF158K1 for Treatment of HER2 low and HER2+ Cancers

HighField Biopharmaceuticals Receives US FDA IND Clearance for Phase 1 Trial of Immunoliposome HF158K1 for Treatment of HER2 low and HER2+ Cancers
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dan eramianYuhong xuDonald wyattHighfield bioBusiness development contactOpus biotech communicationsDrug administrationField biopharmaceuticalsInvestigational new drugField bioDevelopment contact

NanOlogy Presents Clinical Research at 2023 DDW and ASCO Involving its Large Surface Area Microparti

FORT WORTH, Texas (BUSINESS WIRE) NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle (LSAM) investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.The DDW poster entitled “Intracystic Injecti.

South koreaDan eramianHolly maulhardtSomashekar krishnaShelagh vercoOpus biotech communicationsOhio state university wexner medical centerLarge surface area microparticle paclitaxelIntraductal papillary mucinous neoplasmsExpanded access protocolOhio state university wexner medicalEndosc int openPrivate securities litigation reform act

HighField Biopharmaceuticals HF1K16, a New Immuno-Oncology Drug, Shows Promise in Patients with Refractory Glioblastoma | Illinois

HANGZHOU, China (BUSINESS WIRE) May 31, 2023

Mccormick placeUnited statesHighfield bioDonald wyattYuhong xuDan eramianBusiness development contactAmerican society of clinical oncologyOpus biotech communicationsField biopharmaceuticalsAmerican societyClinical oncologyMyeloid derived suppressor cellsField bioMedia contactDevelopment contact

Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic Gout at American College of Rheumatology Annual Meeting, Nov 10 – 14, in Philadelphia, PA

Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic Gout at American College of Rheumatology Annual Meeting, Nov 10 – 14, in Philadelphia, PA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam shiN lawrence edwardsRoyj wuDan eramianMarc gurwithBusiness development contactCo ltdDivision of clinical immunologyDivision of rheumatologyUniversity of alabamaUniversity of floridaAmerican college of rheumatologyOpus biotech communicationsDepartment of medicineBusiness development